CRC has an immunosuppressive TME which prevents the event of an efficient reaction to ICB therapies. There may be thus an urgent really need to recognize the methods reprogram this suppressive TME in an effort to greatly enhance immunotherapy efficacy. In The present analyze, we employed CRISPR KO s